Lineage Cell Therapeutics
LCTX
#8828
Rank
A$0.17 B
Marketcap
$0.79
Share price
-0.62%
Change (1 day)
-50.28%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -A$33.88 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are A$8.71 Million. In 2023 the company made an earning of -A$39.16 Million a decrease over its 2022 earnings that were of -A$35.66 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$33.88 Million-13.49%
2023 -A$39.16 Million9.83%
2022 -A$35.66 Million-54.24%
2021 -A$77.92 Million86.07%
2020 -A$41.88 Million-31.97%
2019 -A$61.55 Million-5.42%
2018 -A$65.08 Million1.1%
2017 -A$64.37 Million-31.06%
2016 -A$93.36 Million-10.38%
2015 -A$0.11 Billion29.69%
2014 -A$80.34 Million31.68%
2013 -A$61.01 Million
2011 -A$29.61 Million89.78%
2010 -A$15.6 Million206.06%
2009 -A$5.1 Million-0.58%
2008 -A$5.13 Million164.89%
2007 -A$1.94 Million-30.22%
2006 -A$2.78 Million
2002 -A$3.23 Million-41.04%
2001 -A$5.47 Million-32.04%
2000 -A$8.04 Million-11.85%
1999 -A$9.12 Million
1997 -A$5.86 Million12.12%
1996 -A$5.23 Million106.25%
1995 -A$2.54 Million-11.11%
1994 -A$2.85 Million50%
1993 -A$1.9 Million20%
1992 -A$1.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.22 Billion 492.84%๐Ÿ‡บ๐Ÿ‡ธ USA